Core Viewpoint - The company has successfully transferred its 11.11% stake in Nanjing Tianshi Software Technology Co., Ltd. for a total price of RMB 1,748.00 million, marking a strategic divestment from this investment [1] Group 1: Transaction Details - The company announced the public transfer of its 11.11% stake in Nanjing Tianshi on December 5, 2025, through the Shanghai United Assets and Equity Exchange, with an initial listing price of RMB 1,747.31 million [1] - On January 13, 2026, the company signed a contract with Nanjing Zhongheng Electric Co., Ltd. for the transfer of the stake at a price of RMB 1,748.00 million [1] - The company has received the full payment for the stake transfer and has completed the necessary industrial and commercial registration changes, resulting in no remaining ownership in Nanjing Tianshi [1]

Core Viewpoint - The company is focusing on the transformation and development of its main businesses in traditional Chinese medicine circulation, medical services, and clothing wholesale and retail, aligning with local economic policies aimed at high-quality development [1] Group 1: Business Segments - The company is engaged in traditional Chinese medicine circulation and medical service (traditional Chinese consultation services) as its main businesses [1] - In the pharmaceutical sector, the company is pursuing a "big health" transformation, actively developing regional SPD business and exploring new projects such as the Lei Yun Shang dental project [1] - In the clothing sector, the company is enhancing operational efficiency by leveraging the results of comprehensive reforms aimed at improving quality and efficiency, while also focusing on the inheritance and innovation of its time-honored brands [1] Group 2: Subsidiary Information - Shanghai Dingfeng Technology Development Company, in which the company holds a 44.44% stake, is involved in various sectors including information technology, biomedicine, new energy, new materials, high-tech agriculture, and environmental protection [1] - The subsidiary's business includes technology development, consulting, services, and sales of new energy products, new materials, environmental equipment, metal materials, construction materials, hardware, electrical appliances, and communication equipment [1]

| 股票代码：600272 | 股票简称：开开实业 | | | 编号：2026—004 | | --- | --- | --- | --- | --- | | 900943 | | 开开 | 股 B | | 上海开开实业股份有限公司 关于注销募集资金专项账户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 二、募集资金管理情况 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意上海开开实业股份有限公 司向特定对象发行股票注册的批复》，并经上海证券交易所同意，上海 开开实业股份有限公司（以下简称"公司"）向特定对象发行人民币普 通股（A 股）股票 19,651,945 股，募集资金总额为 158,984,235.05 元， 扣除与发行相关的费用 3,494,204.02 元（不含税），募集资金净额为 155,490,031.03 元。根据《上海开开实业股份有限公司向特定对象发行 A 股股票募集说明书（注册稿）》中披露的募集资金用途，公司本次向特 定对象发行 A 股股票募集资金在扣除相关发行费用后，将全部用于补充 ...

| | | 上海开开实业股份有限公司 关于使用闲置自有资金购买银行理财产品的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 股票代码：600272 股票简称：开开实业 编号：2026-003 900943 开开 B 股 重要内容提示： 履行的审议程序：2025年4月28日上海开开实业股份有限公司（以下 简称： "公司"）召开第十届董事会第二十五次会议，以9票同意、0票反 对、0票弃权的表决结果，审议通过了《关于董事会授权购买低风险理财产 品的议案》，授权公司总经理室在2025年4月至2026年4月期间，阶段性的 继续利用短期闲置资金总金额不超过人民币1.8亿元，购买低风险理财产品。 在上述额度内资金可以滚动使用。在资金额度的使用期限内任一时点的交 易金额（含前述投资的收益进行再投资的相关金额）不超过该投资额度。 本议案无需提交股东大会审议。 特别风险提示：公司本着审慎投资的原则拟投资的品种包括结构性 存款等理财产品，以及安全性较高、流动性较好、短期（不超过12个月） 的其他低风险理财产品。总体投资风险小，处于公司风险 ...

Core Viewpoint - The company, Kaikai Industrial (600272.SH), anticipates a significant decrease in net profit for the year 2025, projecting approximately 12.9 million yuan, which represents a decline of about 63.14% compared to the previous year [1] Group 1: Financial Performance - The expected net profit for 2025 is around 12.9 million yuan, a decrease of approximately 22.1 million yuan from the previous year [1] - The projected decline in net profit is approximately 63.14% year-on-year [1] Group 2: Strategic Initiatives - The company is steadily advancing its "big health" strategic transformation and actively expanding into emerging businesses [1] - Ongoing upgrades and optimizations of retail stores are being conducted alongside the new business initiatives [1] Group 3: Market Conditions - The company faces challenges due to industry cyclical fluctuations and macroeconomic conditions, leading to cautious consumer spending on high-end health products [1] - In response to market changes, the company has adjusted its product sales structure, which has contributed to a temporary decline in operational performance [1]

Group 1 - The company, Kaikai Industrial, announced a profit warning for the year 2025, projecting a net profit attributable to shareholders of approximately 12.90 million yuan [2] - This represents a decrease of about 22.10 million yuan compared to the same period last year, indicating a year-on-year decline of approximately 63.14% [2]

Core Viewpoint - The company, Kaikai Industrial (600272.SH), expects a significant decline in net profit for the year 2025, indicating potential challenges ahead for its financial performance [1] Financial Performance - The company anticipates a net profit attributable to shareholders of approximately 12.9 million yuan for the year 2025, which represents a decrease of about 22.1 million yuan compared to the previous year, reflecting a year-on-year decline of approximately 63.14% [1] - The expected net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be around -2.9 million yuan for 2025, indicating a reduction of about 4.99 million yuan compared to the same period last year, which corresponds to a year-on-year decrease of approximately 238.48% [1]

Financial Performance - The company expects a net profit attributable to shareholders of approximately CNY 12.90 million for 2025, a decrease of about CNY 22.10 million or 63.14% compared to the previous year[3] - The expected net profit attributable to shareholders after deducting non-recurring gains and losses is approximately CNY -2.90 million, a decrease of about CNY 4.99 million or 238.48% year-on-year[3] - The total profit for the year 2024 was CNY 66.53 million, with a net profit attributable to shareholders of CNY 34.99 million[6] - The previous year's net profit attributable to shareholders was CNY 34.99 million, leading to a larger percentage change in the current year's performance[10] Strategic Transformation - The company is undergoing a strategic transformation towards "big health," which involves new business development and retail store upgrades, impacting short-term profitability[7] Non-Operating Income - Non-operating income decreased significantly due to the absence of similar compensation gains from property acquisition in the previous year, which amounted to CNY 32.95 million[8] Performance Forecast - The company does not foresee any major uncertainties affecting the accuracy of the performance forecast[13] - The data provided is preliminary and subject to final audit in the official 2025 annual report[14]

Core Viewpoint - Shanghai Kaikai Industrial Co., Ltd. has publicly transferred 11.11% equity of Nanjing Tianshi Software Technology Co., Ltd. for a price of RMB 17.48 million, enhancing investment efficiency and focusing on core business operations [2][26]. Transaction Overview - The company approved the transfer of 11.11% equity of Nanjing Tianshi at a board meeting on August 1, 2025, with an asset valuation of RMB 157.27 million as of December 31, 2024 [4][26]. - The transfer price was set at RMB 1,747.31 million, corresponding to the assessed value of the equity [4][26]. Transaction Progress - The equity was publicly listed for transfer on December 5, 2025, with Nanjing Zhongheng Electric Co., Ltd. as the sole qualified buyer, agreeing to a transaction price of RMB 17.48 million [5][26]. - The transaction does not constitute a related party transaction or a major asset restructuring [6][26]. Buyer Information - Nanjing Zhongheng Electric Co., Ltd. was established on December 10, 2009, with a registered capital of RMB 4.3 million [6][7]. - The company has a good credit standing and is capable of fulfilling the transaction obligations [9]. Contractual Details - The contract stipulates that the transaction price is RMB 17.48 million, with a one-time payment structure [13][15]. - The transfer of rights is to be completed within 30 working days post-contract signing [18][26]. Impact on Company - The transfer of equity will improve investment efficiency, reduce investment risks, and optimize the investment structure, without adversely affecting the company's future financial status [26]. - Post-transaction, the company will no longer hold equity in Nanjing Tianshi, allowing it to focus on its core business and implement a strategic transformation towards the "big health" industry [26].

| 股票代码：600272 | 股票简称：开开实业 | | | 编号：2026—001 | | --- | --- | --- | --- | --- | | 900943 | | 开开 | B 股 | | 上海开开实业股份有限公司 关于转让南京天石软件技术有限公司 11.11%股权的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 上海开开实业股份有限公司（以下简称"公司"）已经通过上海联 合产权交易所以公开挂牌转让的方式将所持有的南京天石软件技术有限 公司（以下简称"南京天石"）11.11%股权进行转让，挂牌价格为人民币 1,747.31 万元。挂牌期间共征集到一个合格意向受让方：南京众恒电气 有限公司，交易价格为人民币 1748.00 万元。公司于近日与受让方签订 了《上海市产权交易合同》。 本次交易不构成关联交易。 本次交易不构成重大资产重组。 本次交易已经公司第十届董事会第二十七次会议审议通过，无需 提交公司股东会审议，交易实施不存在重大法律障碍。 一、交易概述 经上海开开实业股份有限公司 ...